You have 9 free searches left this month | for more free features.

Immunomodulatory drug

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Assessment of Risk (CLEAR) Study

Completed
  • Cardiovascular Disease
    • Box Hill, Victoria, Australia
    • +3 more
    Apr 11, 2022

    Lung Transplant; Complications Trial in Nashville (Tacrolimus Extended Release Oral Tablet [Envarsus], Tacrolimus, Mycophenolate

    Not yet recruiting
    • Lung Transplant; Complications
    • Tacrolimus Extended Release Oral Tablet [Envarsus]
    • +4 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jun 6, 2022

    Alzheimer Trial in United States (Bryostatin, Placebo)

    Completed
    • Alzheimer Disease
    • Fresno, California
    • +27 more
    Sep 8, 2020

    Macular Edema Trial in United States (Updated Dexamethasone Posterior Segment Drug Delivery System, Approved Dexamethasone

    Completed
    • Macular Edema
    • Updated Dexamethasone Posterior Segment Drug Delivery System
    • Approved Dexamethasone Posterior Segment Drug Delivery System
    • Glendale, California
    • +6 more
    Feb 11, 2022

    Rheumatoid Arthritis Trial in Worldwide (Olokizumab 64mg q4w, Olokizumab 64mg q2w, Adalimumab 40mg q2w)

    Completed
    • Rheumatoid Arthritis
    • Olokizumab 64mg q4w
    • +3 more
    • Mesa, Arizona
    • +244 more
    Apr 6, 2021

    Food-drug Interaction Trial in Chicago (Licorice, Alprazolam 2 MG, Caffeine 100 MG)

    Active, not recruiting
    • Food-drug Interaction
    • Licorice
    • +4 more
    • Chicago, Illinois
      University of Illinois at Chicago
    Apr 28, 2021

    Epithelial Tumors, Malignant, Epithelial Tumors, Malignant, Malignant Mesenchymal Tumor Trial run by the NCI (NHS-IL-12)

    Completed
    • Epithelial Neoplasms, Malignant
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Oct 15, 2021

    Study of Predictors of Response to Anti Epilepsy in Epilepsy

    Terminated
    • Seizure
      • Lille, France
        Hôpital Roger Salengro, CHRU de Lille
      Mar 9, 2021

      Chronic Renal Insufficiency Trial in Orlando, Knoxville (LHW090, Placebo)

      Completed
      • Chronic Renal Insufficiency
      • Orlando, Florida
      • +1 more
      Dec 16, 2020

      Smoking Cessation, Micronuclei Trial in Switzerland (ENDS (vaporizer/e-cig) and smoking cessation counseling, Smoking cessation

      Active, not recruiting
      • Smoking Cessation
      • Micronuclei
      • ENDS (vaporizer/e-cig) and smoking cessation counseling
      • Smoking cessation counseling
      • Lausanne, Vaud, Switzerland
      • +4 more
      Feb 11, 2022

      Alzheimer Trial in Ramat Gan (SCI -110)

      Recruiting
      • Alzheimer Disease
      • SCI -110
      • Ramat Gan, Israel
        The Israeli Medical Center for Alzheimer's
      Feb 3, 2022

      Analgesia, Patient-Controlled Trial in Shenyang (intravenous sufentanil, subcutaneous sufentanil, intravenous hydromorphone)

      Completed
      • Analgesia, Patient-Controlled
      • intravenous sufentanil
      • +7 more
      • Shenyang, Liaoning, China
        The First Affiliated Hosipital of China Medical University
      Feb 8, 2021

      Carcinoma, Non-small Cell Lung Trial in Spain, United States (Abemaciclib, Pemetrexed, Gemcitabine)

      Completed
      • Carcinoma, Non-small Cell Lung
      • Fayetteville, Arkansas
      • +10 more
      Aug 22, 2020

      Induction of Labor Trial in Ludhiana (Oral misoprostol solution (OMS))

      Completed
      • Induction of Labor
      • Oral misoprostol solution (OMS)
      • Ludhiana, Punjab, India
        Christian Medical College and Hospital
      May 13, 2021

      Psychotic Disorders, Stress Disorders, Traumatic, Substance Use Trial in Halifax (Prolonged exposure (PE)+ therapy, Treatment as

      Recruiting
      • Psychotic Disorders
      • +2 more
      • Prolonged exposure (PE)+ therapy
      • Treatment as usual (TAU)
      • Halifax, Nova Scotia, Canada
        Nova Scotia Early Psychosis Program (NSEPP), Abbie J. Lane Memor
      Apr 1, 2022

      Multimodal Neuromonitoring

      Recruiting
      • Subarachnoid Hemorrhage
      • +5 more
        • Vienna, Austria
          Department of Neurosurgery, Medical University of Vienna
        Jan 31, 2021

        Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma Trial in Iowa City (68Ga-DOTATOC PET/CT)

        Completed
        • Neuroendocrine Tumors
        • +3 more
        • 68Ga-DOTATOC PET/CT
        • Iowa City, Iowa
          University of Iowa Health Care
        Jul 24, 2021

        Called EPI VITRAKVI to Compare Treatment Results in Infantile

        Completed
        • Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion
        • Infantile Fibrosarcoma
        • Larotrectinib (Vitrakvi, BAY2757556)
        • Standard of Care
        • Multiple Locations, France
          Multiple Locations
        Jan 10, 2023

        Asthma, Bronchial Asthma Trial in Amsterdam, Groningen, London (Bronchial thermoplasty, Alair system (Boston Scientific, USA))

        Completed
        • Asthma
        • Bronchial Asthma
        • Bronchial thermoplasty
        • Alair system (Boston Scientific, USA)
        • Amsterdam, Noord Holland, Netherlands
        • +2 more
        Apr 8, 2020

        Adherence, Medication, Risk Reduction, Drug Use Trial in New York (PARTNER, Education Intervention)

        Recruiting
        • Adherence, Medication
        • +4 more
        • PARTNER
        • Education Intervention
        • New York, New York
          Center for HIV Educational Studies and Training; Hunter College
        Nov 13, 2020

        Neuromuscular Blockade in Intentive Care Unit,Observational

        Completed
        • Critical Care
        • +2 more
        • Neuromuscular Blocking Agents
        • Argenteuil, France
        • +10 more
        Dec 15, 2021

        ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and

        Unknown status
        • Breast Cancer Patients
        • polymorphism analysis
        • Doxorubicin-Cyclophosphamide regimen
        • Cairo, Egypt
          Elhussien University Hospital
        Nov 29, 2020

        Tuberculosis Trial in Gaziantep (Treatment adherence)

        Completed
        • Tuberculosis
        • Treatment adherence
        • Gaziantep, Turkey
          Gaziantep University
        Jan 20, 2022

        Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg

        Recruiting
        • Tuberculosis, Pulmonary
        • +4 more
        • Johannesburg, South Africa
        • +2 more
        Oct 4, 2021